Filters
Micronized phenofibrate and LDL-cholesterol subfraction
Small dense LDL blood concentration which increases risk of coronary heart disease is reduces with phenofibrate treatment......
FB - Endokrinologie, diabetologie, metabolismus, výživa
- 1999 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Disorders of lipids metabolism and atherosclerosis
and the presence of small, dense LDL. Pro-atherogenic changes associated and VLDL remnants, small dense LDL, low HDL-cholesterol, and prothrombogenic changes triglycerides, the presence of sm...
FB - Endokrinologie, diabetologie, metabolismus, výživa
- 2001 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism
common causes of secondary dyslipidemias which results from reduced LDL clearance and thereforeraised levels of LDL and apoB. Association between small dense LDL (sdLDL replacement or thyreo-suppressive t...
EB - Genetika a molekulární biologie
- 2014 •
- Jx •
- Link
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators-A pilot
density lipoprotein cholesterol (LDL-C), high density cholesterol (HDL-C), triglycerides (TG), LDL-C sub-fractions [large LDL-C 1-2 and small dense (sd)-LDL-C 3-7......
FS - Lékařská zařízení, přístroje a vybavení
- 2015 •
- Jx •
- Link
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
LDL-C or apoB as the best target for reducing coronary heart disease: should apoB be implemented into clinical practice?
LDL-C and non-HDL-C targets remain at high risk owing to high levels of apoB, especially subjects with the prevalence of small dense LDL. With the worldwide increasingLDL-C is considered to be the major l...
FB - Endokrinologie, diabetologie, metabolismus, výživa
- 2011 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
What is the role of nutriceuticals in dyslipidemia management? Armolipid Plus
clinical studies are presented; this nutriceutical reduces LDL-C by 15-30 % and glucose level. Armolipid Plus changed the size and density of LDL particles from small denseLow density lipoprotein-cholesterol (...
Cardiac and Cardiovascular systems
- 2017 •
- Jost
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Atherogenic dyslipidemia typical for metabolic syndrome
Atherogenic dyslipidemias plays an important role in determining the cardiovascular risk. In these patients, insulin resistance is responsible for overproduction and secretion of atherogenic very low denstiy lipoprotein. In addition, insulin resistan...
Endocrinology and metabolism (including diabetes, hormones)
- 2020 •
- JSC •
- Link
Rok uplatnění
JSC - Článek v periodiku v databázi SCOPUS
Výsledek na webu
Current treatment options for patients with dyslipidemia and cardiometabolic syndrome
cholesterol andsmall dense LDL particles) characterizes typical atherogenic dyslipidaemia in the patients with insulin resistance. High cardiovascular risk is done by small dense LDL......
FA - Kardiovaskulární nemoci včetně kardiochirurgie
- 2015 •
- O
Rok uplatnění
O - Ostatní výsledky
Diabetes, dyslipidemia and atherosclerosis
and mildlyelevated or normal levels of LDL-cholesterol. Their LDL-particles are however small, dense and highly atherogenic. These patients often have other, genetically dyslipidemia with heightened LDL-c...
FA - Kardiovaskulární nemoci včetně kardiochirurgie
- 2013 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Importance of determining apolipoproteins B and A-1 in clinical practice.
of small dense LDL (sdLDL). According to the ESC/EAS 2011 guidelines, ApoB should...
FB - Endokrinologie, diabetologie, metabolismus, výživa
- 2012 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
- 1 - 10 out of 50 598